Business
our business, operations, and financial performance and condition as well as our plans, objectives, and expectations for business operations and financial performance and condition.
Nuvation Bio Inc.: Revenue grew 699% to $62.9M from $7.873M. Net loss narrowed to $205M from $568M. Operating cash flow outflow widened to $173M from $130M. Operating margin expanded 718861 bps to -338.72%. Nuvation Bio Inc.'s annual comparison also shows the balance-sheet screen falls in the distress range and requires business-model context.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 699% to $62.9M from $7.873MOK
- Profitability — Net loss narrowed to $205M from $568MOK
- Cash flow — Operating cash flow outflow widened to $173M from $130MNote
- Margins — Operating margin expanded 718861 bps to -338.72%OK
- Accounting — Distress-range screen needs contextWatch
- Insiders — 0 purchases and 12 salesWatch
Where the revenue comes from
Fiscal 2025, as Nuvation Bio Inc. reports it. History and quarterly detail are in the app.
- License$38.2M
- Product Revenue$24.7M
- Product$24.7M
- Research And Development Service Revenue$5.3M
- Royalty Revenue$1.1M
Leadership changes
From Nuvation Bio Inc.'s own filings, the day they're filed.
- Philippe Sauvage · Chief Financial Officer · appointmenteff. 2024-10-07
- Oleg Nodelman · Directors · departureeff. 2023-12-11
- Moses Makunje · Principal Accounting Officer · appointmenteff. 2023-11-27
Latest filings
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-07-06
- 8-K · Company announcement2026-06-30
- 8-K · Company announcement2026-05-27
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Nuvation Bio Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.